Side-by-side comparison of AI visibility scores, market position, and capabilities
Beverly Hills live entertainment (NYSE: LYV) $23.2B FY2024 revenue (+6.7%); Ticketmaster 550M+ tickets, Taylor Swift Eras Tour $2.08B, DOJ antitrust breakup case, competing with AEG Presents.
Live Nation Entertainment, Inc. is a Beverly Hills, California-based live entertainment company — publicly traded on the New York Stock Exchange (NYSE: LYV) as an S&P 500 Communication Services component — operating as the world's largest live entertainment company through three integrated business segments: Concerts (promoting and producing 40,000+ events annually featuring 5,500+ artists at Live Nation-operated and third-party venues worldwide), Ticketing (Ticketmaster — the dominant US and global ticketing platform processing 550+ million tickets annually), and Sponsorship & Advertising (brand partnership and naming rights revenue across Live Nation venues and events) through approximately 44,000 employees globally. In fiscal year 2024, Live Nation reported revenues of $23.2 billion (+6.7% year-over-year), with concerts segment revenue growing on sustained post-COVID touring normalization and stadium-scale demand for A-list artists (Taylor Swift's Eras Tour — the highest-grossing concert tour in history at $2.08 billion globally in 2023-2024 — Beyoncé Renaissance tour, Coldplay, Morgan Wallen creating record venue sell-throughs). CEO Michael Rapino has executed Live Nation's vertically integrated live entertainment flywheel for two decades: artist management (Front Line Management), concert promotion (Live Nation Concerts), venue operation (House of Blues, Palladium, Amphitheater network — 350+ owned/operated venues), and ticketing (Ticketmaster) — creating a system where artists book through Live Nation-managed agents, play Live Nation-promoted shows, in Live Nation-operated venues, with tickets sold exclusively through Ticketmaster, capturing revenue at every transaction layer.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.